AI Technology Group Inc. has amended the terms of its previously announced merger with AVM Biotechnology Inc. and Biomed 360 Solutions Corp. The updated agreement outlines revised investment obligations, including confirmation of $1 million in loans provided by August 1, 2025, and an additional $1 million by November 20, 2025. Further investments of $1 million each are scheduled for February 28, April 30, and June 30, 2026. Additionally, a minimum of $10 million and up to $25 million is set to be invested on or before the newly extended closing date of July 26, 2026. All convertible loan amounts from Tranche 2 and 3 will accrue 10% annual simple interest and may be settled in shares at the effective time.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AI Technology Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-000500), on January 29, 2026, and is solely responsible for the information contained therein.